CDIB Capital Group is a Taipei-based private equity and venture capital firm, and the PE/asset management arm of KGI Financial Holding. Formerly China Development Industrial Bank, it invests across venture, growth equity, buyouts, and private credit with a focus on the Asia-Pacific region.
Average disclosed round size is $44.4M (across 17 rounds with reported amounts).
Portfolio
17
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Alex Ying
Managing Director at CDIB Capital International
Gary Fung
Managing Director at CDIB Capital International
Robert Liu
Managing Director at CDIB Yida Healthcare Private Equity Management Corporation
Zhen Ji
Managing Director at CDIB Capital International
Ching-Ting Lin
Independent Director
Grace Lei
Independent Director
Jeff Lin
Independent Director
Jocelyn Huang
Director
Daniel Tsou
Executive Vice President at CDIB Capital Management Corporation
Frances Tsai
Executive Vice President at CDIB Capital Group
Jay Huang
Executive Vice President at CDIB Capital Group
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Aidoc | Series D | $110M | Jun 2022 |
 Instadeep | Series B | $100M | Jan 2022 |
| XXrex Inc. | Seed | $17M | Aug 2021 |
 Unabiz Holdings | Series B | $25M | Jan 2021 |
| HHaoxinqing | Series A | $125M | May 2020 |
| XXWPharma | Series C | $40M | Jan 2020 |
| HHaoxinqing | Series A | $17.7M | Jan 2020 |
 KKday | Series B | — | Nov 2018 |
 Rokid | Series B | — | Jan 2018 |
| Ccitiesocial | Series A | $2.8M | Jan 2018 |
| XXWPharma | Series B | $17.5M | Jan 2017 |
 iCHEF | Series A | $5.6M | Feb 2016 |
| XXWPharma | Series A | — | Jan 2014 |
 Broadlogic | Series C | $20M | Jan 2004 |
| PPeregrine Semiconductor | Unknown | $23M | Feb 2003 |
 XREX | Seed | $17M | — |
 Boxed | Unknown | $111M | — |
 Vpon Holdings | Series B | $7M | — |
 Umbo Computer Vision | Series A | $6.8M | — |
| AAidoc Medical Ltd. | Series D | $110M | — |
Top Co-Investors
Last updated: 9 September 2026